|Position||Trades||Duration||Win rate||Win/loss||Avg win||Avg loss||Return|
|Position||Trades||Duration||Win Rate||Win/Loss||Avg Win||Avg Loss||Return|
Nanostring Tech (NSTG)
SINE WEIGHTED MOVING AVERAGE
Trading: SELL @ $25.43
Signal Strength: STRONG
Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. This indicator has the ability to highlight trends across numerous timeframes. This indicator has the ability to smooth historical results to illustrate trend initiation and status. Although this is a simple trend following indicator & can provide good results when coupled with the right indicator. Note, this indicator does not work well in ranging markets producing unwanted whipsaws and false signals.
Nanostring Tech (NASDAQ:NSTG) currently has a confirmed downtrend. Recent trading has caused the SWMA 15 day average to move below the closing price confirming the short term trend following indicator. Currently, the return on SWMA15 is -0.7%.
A Sine wave is a smooth repetitive oscillation that shifts between a high of y and a low of -y. A SW-MA takes its weighting from the first half of a Sine wave cycle so the largest weighting is given to the data in the middle. The result is very similar to the Triangular Moving Average (Tri-MA) but much more difficult to calculate.
Calculation: Sine Weighted Moving Average (SWMA):
4) S2:=Sin(2*180/6)*Ref(C -1);
5) S3:=Sin(3*180/6)*Ref(C -2);
6) S4:=Sin(4*180/6)*Ref(C -3);
7) S5:=Sin(5*180/6)*Ref(C -4);
PROFILE: Nanostring Tech (NSTG)
Stock Exchange: NASDAQ
Company: Nanostring Tech
Ticker Codes: | NSTG | NASDAQ:NSTG |
NanoString Technologies, Inc. provides life science tools for translational research and molecular diagnostic products worldwide. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; and Pan Cancer and 360 gene expression, protein immune profiling, neuropathology and neuro-inflammation gene expression, autoimmune disease gene expression, nCounter Vantage 3D, miRNA expression, cancer copy number variation, and other gene expression panels. Further, the company offers nCounter-based reagents that allow users to design customized assays; Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and nCounter Dx Analysis System and Prosigna molecular diagnostic test kits. It has collaboration with Celgene Corporation; Merck & Co., Inc.; Medivation, Inc.; and Astellas Pharma, Inc., as well as the Cancer Therapy Evaluation Program of the National Cancer Institute. The company was founded in 2003 and is headquartered in Seattle, Washington.
|CARA Cara Therapeutics||17.15||4.6||572,674||-13.2||BEARISH|
|OMER Omeros Corporation||13.59||2.9||232,893||-3||BEARISH|
|MOBL Mobileiron Inc||4.69||2.9||357,189||0||BEARISH|
|TPIC Tpi Composites||17.05||2.2||192,382||-1.8||BEARISH|
|KNSL Kinsale Capital||98.13||2.1||79,834||-0.8||BEARISH|